Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells

Biochimica et Biophysica Acta - Biomembranes

Volumn 1329, Issue 2, 1997, Pages 345-356

  Filion, Mario C ^a   Phillips, Nigel C ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Antisense oligonucleotide; Cationic lipid; Cationic liposome; Immunoadjuvant; Toxicity

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LIPOSOME; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; EFFECTOR CELL; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE; TOXICITY;

ANIMALS; CELL LINE; DRUG CARRIERS; FEMALE; GENETIC VECTORS; HUMANS; LIPOSOMES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MONOCYTES; OLIGONUCLEOTIDES, ANTISENSE; PHAGOCYTOSIS; PHOSPHOLIPIDS; PLASMIDS; QUATERNARY AMMONIUM COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES;

MAMMALIA; MURINAE;

EID: 0030670810     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(97)00126-0     Document Type: Article

References (38)

1. Rojanasakul Y. Adv. Drug Delivery. 18:1996;115-131.
2. Farhood H., Serbina N., Huang L. Biochim. Biophys. Acta. 1235:1995;289-295.
3. Smith J.G., Walzem R.L., German J.B. Biochim. Biophys. Acta. 1154:1993;327-340.
4. Caplen N.J., Alton E.W., Middleton P.G., Dorin J.R., Stevenson B.J., Gao X., Durham S.R., Jeffrey P.K., Hodson M.E. Nature Med. 1:1995;39-46.
5. Aoki K., Yoshida T., Sugimuna T., Terada M. Cancer Res. 55:1995;3810-3816.
6. Lappalainen K., Jääskeläinen I., Syrjänen K., Urtti A., Syrjänen S. Pharm. Res. 11:1994;1127-1131.
7. Canonico A.E., Plitman J.D., Canary J.T., Meyrick B.D., Brigham K.L. J. Appl. Physiol. 77:1994;415-419.
8. Cappacioli S., Di Pasquale G., Mini E., Mazzei T., Quattrone A. Biochim. Biophys. Res. Commun. 197:1993;818-825.
9. Velinova M., Read N., Kirby C., Gregoriadis G. Biochim. Biophys. Acta. 1299:1996;207-215.
10. Filion M.C., Proulx C., Bradley A.J., Devine D.V., Sékaly R.P., Décary F., Chartrand P. Blood. 88:1996;2144-2150.
11. Dugas B., Debré P., Moncada S. Res. Immunol. 146:1995;664-670.
12. Vassalli P. Ann. Rev. Immunol. 10:1992;411-452.
13. Filion M.C., Bradley A.J., Devine D.V., Décary F., Chartrand P. Eur. J. Immunol. 25:1995;3123-3127.
14. Phillips N.C., Gagné L. J. Drug Target. 3:1995;137-147.
15. Vertut-Doï A., Ishiwata H., Miyajima K. Biochim. Biophys. Acta. 1278:1996;19-28.
16. M. Whitt, L. Buonocore, J.K. Rose, Short protocols in molecular biology, 3rd ed., John Wiley and Sons, Chichester, 1995, pp. 9.13-9.14.
17. Van Rooijen N., Nieuwmegen R. Meth. Enzymol. 93:1983;83-95.
18. G. Storm, C. Oussoren, P.A.M. Peeters, Y. Barenholz, Liposome technology, 2nd ed., Vol. III, CRC Press, Boca Raton, 1993, pp. 345-383.
19. Stewart M.J., Plautz G.E., Del Buono L., Yanz Z.Y., Xu L., Gao X., Huang L., Nabel E.G., Nabel G.J. Hum. Gene Ther. 3:1992;267-275.
20. Adams D.O., Hamilton T.A. Ann. Rev. Immunol. 2:1984;283-318.
21. Harding C.V., Collins D.S., Kanagawa O., Unanue E.R. J. Immunol. 147:1991;2860-2863.
22. Waldrep J.C., Kaplan A.M., Mohanakumar T. J. Reticuleoendoth. Soc. 34:1983;323-330.
23. Zhou X., Huang L. Biochim. Biophys. Acta. 1189:1994;195-203.
24. Litzinger D., Huang L. Biochim. Biophys. Acta. 1113:1992;201-227.
25. N.C. Phillips, L. Gagné, N. Ivanoff, G. Riveau, Vaccine 14 (1996) 898, 904.
26. Senior J.H., Trimble K.R., Maskiewicz R. Biochim. Biophys. Acta. 1070:1991;173-179.
27. Litzinger D.C., Brown J.M., Wala I., Kaufman S.A., Van G.Y., Farrell C.L., Collins D. Biochim. Biophys. Acta. 1281:1996;139-149.
28. Bottega R., Epand R.M. Biochem. 31:1992;9025-9030.
29. Farhood H., Bottega R., Epand R.M., Huang L. Biochim. Biophys. Acta. 1111:1992;239-246.
30. Severn A., Wakelam M.J.O., Liew F.Y. Biochem. Biophys. Res. Commun. 188:1992;997-1002.
31. Kovacs E.J., Radzioch D., Young H.A., Varesio L. J. Immunol. 141:1988;3101-3105.
32. Dean N., McKay R., Miraglia L., Howard R., Cooper S., Giddings J., Nicklin P., Meister L., Ziel R., Geiger T., Muller M., Fabbro P. Canc. Res. 56:1996;3499-3507.
33. Zhang R., Yan J., Shaninan H., Amin G., Lu Z., Liu T., Saag M.S., Jiamg Z., Temsamaini J., Martin R.R., Schechter P.J., Agrawal S., Diasio R.B. Clin. Pharmacol. Ther. 58:1995;44-53.
34. Zhu N., Liggitt D., Liu Y., Debs R. Science. 261:1993;209-211.
35. Yoshihara E., Nakae T. Biochim. Biophys. Acta. 854:1986;93-101.
36. Tan L., Gregoriadis G. Biochem. Soc. Trans. 17:1989;690-691.
37. Chonn A., Cullis P.R., Devine D.V. J. Immunol. 146:1991;4234-4241.
38. R. Malone, Non-viral genetic therapeutics: Advances, challenges and applications for self-assembling systems, IBC's library series, Boston, 1995, pp. 4.1.1.-4.1.26.